☆ 4.7 Article

Dengzhan Shengmai capsule attenuates cardiac fibrosis in post-myocardial infarction rats by regulating LTBP2 and TGF-β1/Smad3 pathway

PHYTOMEDICINE (2023)

Related references

Note: Only part of the references are listed.

Review Cardiac & Cardiovascular Systems

Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development

Timothy A. McKinsey et al.

Summary: Cardiovascular diseases and heart failure have a significant impact on global health and impose a large economic burden. Despite advances in standard care, the risks for death and readmission of heart failure patients are still unacceptably high, necessitating the development of new therapeutic strategies. This review summarizes current knowledge on novel cellular and epigenetic therapies, with a focus on non-coding RNA-based strategies in early clinical development to counteract cardiac remodeling and heart failure. The review also discusses the current status, limitations, and future perspectives of translating these novel therapies into clinical practice.

CARDIOVASCULAR RESEARCH (2023)

Add to Collection

Review Plant Sciences

A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, and pharmacokinetics of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils.

Ke Yang et al.

Summary: Schisandra chinensis and Schisandra sphenanthera, known as bei-wuweizi and nan-wuweizi in Chinese respectively, are highly similar plants with traditional uses in Chinese medicine for treating various conditions. They have similar chemical compositions and pharmacological activities, with potential drug interactions due to their inhibitory effects on CYP3A and P-gp. Further research is needed to explore their traditional uses and differences for clinical applications.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Transforming growth factor-β in myocardial disease

Nikolaos G. Frangogiannis

Summary: Transforming growth factor-beta (TGF beta) plays an important role in myocardial diseases, regulating the phenotype and function of cardiovascular cells, participating in cardiac repair and remodeling.

NATURE REVIEWS CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Current and emerging drug targets in heart failure treatment

Nicolo Ghionzoli et al.

Summary: The neurohormonal interpretative model has laid the foundation for current pharmacological management of heart failure, with drugs targeting detrimental neurohormonal axes and newer approaches focusing on improving cardiac function and remodeling. Emerging therapies are shifting the therapeutic target from neurohormonal systems to the heart, aiming to enhance cardiac contractility, metabolism, fibrosis, inflammation, and remodeling.

HEART FAILURE REVIEWS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting TGF-β signal transduction for fibrosis and cancer therapy

Dandan Peng et al.

Summary: TGF-beta plays essential roles in early embryonic development, organogenesis, immune regulation, tissue repair, and adult homeostasis. Its involvement in fibrosis and cancer is complex and context-dependent, showing both inhibitory and promoting effects. Therapeutics targeting TGF-beta signaling hold promise in treating fibrosis and cancer, although the development is hindered by potential systemic cytotoxicity.

MOLECULAR CANCER (2022)

Add to Collection

Review Plant Sciences

Shengmai san-derived compound prescriptions: A review on chemical constituents, pharmacokinetic studies, quality control, and pharmacological properties

[Anonymous]

Summary: This review provides a comprehensive perspective on the chemical constituents, pharmacokinetics, quality control, and pharmacological properties of Shengmai San Formula (SMS) and its derived compound prescriptions. It also proposes directions for further research and an innovative research paradigm for Chinese materia medica formula.

PHYTOMEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways

Yanghao Chen et al.

Summary: The study aimed to investigate the effect and mechanism of bicyclol on obesity-induced cardiomyopathy. The results demonstrated that bicyclol significantly alleviated myocardial inflammation, fibrosis, and hypertrophy caused by a high-fat diet and palmitic acid stimulation. This effect was achieved by inhibiting the MAPK and NF-kappa B pathways.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

Add to Collection

Article Health Care Sciences & Services

Scutellarin protects against diabetic cardiomyopathy via inhibiting oxidative stress and inflammatory response in mice

Lijiao Xu et al.

Summary: Scutellarin (Scu) protects against diabetic cardiomyopathy by improving cardiac function, reducing heart injury, inhibiting myocardial fibrosis, and increasing antioxidant enzyme activities in diabetic mice.

ANNALS OF PALLIATIVE MEDICINE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies

Mengrui Liu et al.

Summary: Cardiac fibrosis is a major challenge in heart diseases, with myoFbs playing a key role in the fibrotic process. The lack of clear mechanisms and specific targets poses challenges for treatment strategies.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Add to Collection

Article Plant Sciences

Discovery of potential pharmacodynamic ingredients of Dang-Gui-Si-Ni decoction based on absorbed ingredients and molecular docking

Yun Li et al.

Summary: This study aimed to quickly identify potential pharmacodynamic ingredients (PPIs) of DGSN decoction using a multi-dimensional qualitative analysis method. Results revealed 31 compounds identified in the decoction, with 22 compounds absorbed in vivo and 10 compounds detected in portal vein blood. In vitro molecular docking experiments showed 7 compounds exhibited better binding activity with coagulation factors, supporting the PPIs.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-beta/Smad Pathway

Jianheng Pan et al.

Summary: Huangqi Shengmai Yin (HSY) was found to inhibit isoprenaline (ISO)-induced myocardial collagen deposition in rats, leading to improved cardiac function and protection of myocardium by reducing apoptosis and collagen deposition. This suggests that HSY could be a potential therapeutic agent for ameliorating myocardial fibrosis.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Integrative & Complementary Medicine

Breviscapine: A Review on its Phytochemistry, Pharmacokinetics and Therapeutic Effects

Luan Wen et al.

Summary: Breviscapine is an extract of several flavonoids, with scutellarin as the main active component, showing a broad spectrum of pharmacological activities for treating cardiovascular and cerebrovascular diseases. Scutellarin and its analogs hold significant value in drug research and development.

AMERICAN JOURNAL OF CHINESE MEDICINE (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cardiac fibrosis

Nikolaos G. Frangogiannis

Summary: Myocardial fibrosis, characterized by the expansion of cardiac interstitium through deposition of extracellular matrix proteins, is a common pathophysiologic feature in various myocardial conditions. Activated fibroblasts and myofibroblasts play a central role in cardiac fibrosis, producing matrix proteins and triggering fibrogenic signalling cascades in response to stress. Immune cells, vascular cells, and cardiomyocytes can also contribute to fibrosis, while fibrotic changes may disrupt cardiac function and play a role in arrhythmogenesis.

CARDIOVASCULAR RESEARCH (2021)

Add to Collection

Article Physiology

LTBP2 knockdown by siRNA reverses myocardial oxidative stress injury, fibrosis and remodelling during dilated cardiomyopathy

Xue-Feng Pang et al.

ACTA PHYSIOLOGICA (2020)

Add to Collection

Article Cell Biology

Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation

Ling Peng et al.

CELL DEATH & DISEASE (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Biomarkers for the identification of cardiac fibroblast and myofibroblast cells

Emiri Tarbit et al.

HEART FAILURE REVIEWS (2019)

Add to Collection

Article Plant Sciences

Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway

Zifan Zeng et al.

PHYTOMEDICINE (2019)

Add to Collection

Article Medicine, Research & Experimental

Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARα pathway

Xu Chen et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis

Shuin Park et al.

CIRCULATION (2018)

Add to Collection

Article Medicine, Research & Experimental

LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis

Yasunori Enomoto et al.

CLINICAL SCIENCE (2018)

Add to Collection

Article Genetics & Heredity

LTBP2 knockdown and oxidative stress affect glaucoma features including TGF beta pathways, ECM genes expression and apoptosis in trabecular meshwork cells

Fatemeh Suri et al.

GENE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

A Central Bioactive Region of LTBP-2 Stimulates the Expression of TGF-1 in Fibroblasts via Akt and p38 Signalling Pathways

Mohamed A. Sideek et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Add to Collection

Article Medicine, Research & Experimental

Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis

Hadi Khalil et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Add to Collection

Review Medicine, General & Internal

Acute myocardial infarction

Grant W. Reed et al.

LANCET (2017)

Add to Collection

Article Cell Biology

Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar

Mohamed A. Sideek et al.

JOURNAL OF MOLECULAR HISTOLOGY (2016)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cardiac Fibrosis The Fibroblast Awakens

Joshua G. Travers et al.

CIRCULATION RESEARCH (2016)

Add to Collection

Review Biochemistry & Molecular Biology

Latent TGF-β-binding proteins

Ian B. Robertson et al.

MATRIX BIOLOGY (2015)

Add to Collection

Article Pharmacology & Pharmacy

Ophiopogonin D Attenuates Doxorubicin-Induced Autophagic Cell Death by Relieving Mitochondrial Damage In Vitro and In Vivo

Ying-Yu Zhang et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic relevance of PCI-related myocardial infarction

Pier Woudstra et al.

NATURE REVIEWS CARDIOLOGY (2013)

Add to Collection

Review Biochemistry & Molecular Biology

Absorption, Disposition, and Pharmacokinetics of Saponins from Chinese Medicinal Herbs: What Do We Know and What Do We Need to Know More?

Ke Yu et al.

CURRENT DRUG METABOLISM (2012)

Add to Collection

Review Pharmacology & Pharmacy

Everted gut sac model as a tool in pharmaceutical research: limitations and applications

Mohd Aftab Alam et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)

Add to Collection

Article Pharmacology & Pharmacy

Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38-MAPK and ERK1/2

Zhenwei Pan et al.

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Add to Collection

Article Allergy

Angiotensin-Converting Enzyme Inhibitors and Angioedema

Mario Sanchez-Borges et al.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.